Tetrahydrofolic acid

DB00116InvestigationalNutraceuticalSmall molecule

Tetrahydrofolic acid is a folic acid derivative that is produced from dihydrofolic acid after conversion by dihydrofolate reductase. It is converted into 5,10-methylenetetrahydrofolate by serine hydroxymethyltransferase. It is a soluble... It is a soluble coenzyme in many reactions, especially in the metabolism of amino acids and nucleic acids.

Chemical structure of Tetrahydrofolic acid
Mechanism
Curator reviewed
Primary indication
For nutritional supplementation, also for treating dietary shortage or imbalance.Curator reviewed
Formula / weight
C19H23N7O6 · 445.4292 g/mol (avg)
Also known as
Tetrahydrofolate

Resolves to

Clinical / RWD
Structure
InChIKeyMSTNYGQPCMXVAQ-KIYNQFGBSA-NSMILESNC1=NC(=O)C2=C(NCC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2)N1
Transporters

What you can answer from here — as of September 12, 2026

12Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1TransporterSubstrate / inhibitor direction, not just membership
Listed above
33Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
48+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Tetrahydrofolic acid, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account